Literature DB >> 25955836

Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.

Andrew F Auld1, Charity Alfredo, Eugenia Macassa, Kebba Jobarteh, Ray W Shiraishi, Emilia D Rivadeneira, James Houston, Thomas J Spira, Tedd V Ellerbrock, Paula Vaz.   

Abstract

BACKGROUND: During 2004-2009, >12,000 children (<15 years old) initiated antiretroviral therapy (ART) in Mozambique. Nationally representative outcomes and temporal trends in outcomes were investigated.
METHODS: Rates of death, loss to follow-up (LTFU) and attrition (death or LTFU) were evaluated in a nationally representative sample of 1054 children, who initiated ART during 2004-2009 at 25 facilities randomly selected using probability-proportional-to-size sampling.
RESULTS: At ART initiation during 2004-2009, 50% were male; median age was 3.3 years; median CD4% was 13%; median CD4 count was 375 cells/μL; median weight-for-age Z score was -2.1. During 2004-2009, median time from HIV diagnosis to care initiation declined from 33 to 0 days (P = 0.001); median time from care to ART declined from 93 to 62 days (P = 0.004); the percentage aged <2 at ART initiation increased from 16% to 48% (P = 0.021); the percentage of patients with prior tuberculosis declined from 50% to 10% (P = 0.009); and the percentage with prior lymphocytic interstitial pneumonia declined from 16% to 1% (P < 0.001). Over 2652 person-years of ART, 183 children became LTFU and 26 died. Twelve-month attrition was 11% overall but increased from 3% to 22% during 2004-2009, mainly because of increases in 12-month LTFU (from 3% to 18%).
CONCLUSION: Declines in the prevalence of markers of advanced HIV disease at ART initiation probably reflect increasing ART access. However, 12-month LTFU increased during program expansion, and this negated any program improvements in outcomes that might have resulted from earlier ART initiation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25955836      PMCID: PMC7430037          DOI: 10.1097/INF.0000000000000741

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  29 in total

1.  Pediatric HIV--a neglected disease?

Authors:  Marc Lallemant; Shing Chang; Rachel Cohen; Bernard Pecoul
Journal:  N Engl J Med       Date:  2011-08-18       Impact factor: 91.245

2.  Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants.

Authors:  Taha E Taha; Newton Kumwenda; Amanda Gibbons; Donald Hoover; Valentino Lema; Susan Fiscus; Joshua Mukiibi; George Liomba; Robin Broadhead
Journal:  AIDS       Date:  2002-04-12       Impact factor: 4.177

3.  Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009.

Authors:  Geoffrey Fatti; Peter Bock; Brian Eley; Eula Mothibi; Ashraf Grimwood
Journal:  J Acquir Immune Defic Syndr       Date:  2011-11-01       Impact factor: 3.731

4.  Antiretroviral treatment for children with peripartum nevirapine exposure.

Authors:  Paul Palumbo; Jane C Lindsey; Michael D Hughes; Mark F Cotton; Raziya Bobat; Tammy Meyers; Mutsawashe Bwakura-Dangarembizi; Benjamin H Chi; Philippa Musoke; Portia Kamthunzi; Werner Schimana; Lynette Purdue; Susan H Eshleman; Elaine J Abrams; Linda Millar; Elizabeth Petzold; Lynne M Mofenson; Patrick Jean-Philippe; Avy Violari
Journal:  N Engl J Med       Date:  2010-10-14       Impact factor: 91.245

5.  Pathology and causes of death in a series of human immunodeficiency virus-positive and -negative pediatric referral hospital admissions in Botswana.

Authors:  Naseem A Ansari; Ally H Kombe; Thomas A Kenyon; Loeto Mazhani; Nancy Binkin; Jordan W Tappero; Tesfaye Gebrekristos; Samabyawo Nyirenda; Sebastian B Lucas
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

6.  Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.

Authors:  Margaret L McNairy; Matthew R Lamb; Rosalind J Carter; Ruby Fayorsey; Gilbert Tene; Vincent Mutabazi; Eduarda Gusmao; Millembe Panya; Mushin Sheriff; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

7.  Early antiretroviral therapy and mortality among HIV-infected infants.

Authors:  Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

8.  HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.

Authors:  Stanislas Pol; Pascal Lebray; Anais Vallet-Pichard
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

9.  Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia.

Authors:  Maurice Musheke; Virginia Bond; Sonja Merten
Journal:  J Int AIDS Soc       Date:  2012-06-14       Impact factor: 5.396

10.  Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.

Authors:  Franziska Schöni-Affolter; Olivia Keiser; Albert Mwango; Jeffrey Stringer; Bruno Ledergerber; Lloyd Mulenga; Heiner C Bucher; Andrew O Westfall; Alexandra Calmy; Andrew Boulle; Namwinga Chintu; Matthias Egger; Benjamin H Chi
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

View more
  4 in total

1.  Level of Attrition from Antiretroviral Therapy Among Human Immune Deficiency Virus-Infected Children: The Cases of Sidama Zone, Southern Ethiopia.

Authors:  Zemenu Sifr; Telto Ando; Wosenyeleh Semeon; Muse Rike; Kidist Ashami
Journal:  HIV AIDS (Auckl)       Date:  2021-08-13

2.  Mortality among pediatric patients on HIV treatment in sub-Saharan African countries: a systematic review and meta-analysis.

Authors:  Ismael Ahmed; Seblewengel Lemma
Journal:  BMC Public Health       Date:  2019-02-04       Impact factor: 3.295

3.  Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.

Authors:  Richard Makurumidze; Tsitsi Mutasa-Apollo; Tom Decroo; Regis C Choto; Kudakwashe C Takarinda; Janet Dzangare; Lutgarde Lynen; Wim Van Damme; James Hakim; Tapuwa Magure; Owen Mugurungi; Simbarashe Rusakaniko
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

4.  The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.

Authors:  Andrew J Prendergast; Alexander J Szubert; Godfrey Pimundu; Chipo Berejena; Pietro Pala; Annie Shonhai; Patricia Hunter; Francesca I F Arrigoni; Victor Musiime; Mutsa Bwakura-Dangarembizi; Philippa Musoke; Hannah Poulsom; Macklyn Kihembo; Paula Munderi; Diana M Gibb; Moira J Spyer; A Sarah Walker; Nigel Klein
Journal:  AIDS       Date:  2021-08-01       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.